---
schema_version: "secwatch.filing_event.v1"
accession: "0001599298-25-000116"
form_type: "8-K"
ticker: "SMMT"
cik: "0001599298"
company_name: "Summit Therapeutics Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:37:09.132766+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Summit Therapeutics stockholders approve all proposals at 2025 annual meeting

## Summary
- All nine director nominees elected (Duggan, Zanganeh, Soni, Clark, Booth, Cesano, Xia, Ronaghi, Huber) with >98% support.
- Ratification of PwC as independent auditor for FY2025 approved: 653,328,708 for, 195,007 against, 233,629 abstain.
- Non-binding say-on-pay resolution approved: 607,320,353 for, 16,607,648 against, 177,556 abstain.

## SEC filing metadata
- accession: 0001599298-25-000116
- form_type: 8-K
- ticker: SMMT
- cik: 0001599298
- company_name: Summit Therapeutics Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/0001599298-25-000116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/smmt-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001599298-25-000116
- JSON: https://secwatch.observer/filing/0001599298-25-000116.json
- Plain text: https://secwatch.observer/filing/0001599298-25-000116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
